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Abstract 
Purpose: To investigate the effect of the methanol extract of the plant, Stachytarpheta jamaicensis 
(Verbenaceae) (SJ) on uterine smooth muscles of non-pregnant female rats, with the aim of examining 
the oxytocic or otherwise effect of the extract.     
Methods: In the first phase of experiments, the effects of SJ (0.41 and 4.01 mg/ml) on oxytocin (OT) 
induced uterine contractions were determined and repeated after addition of salbutamol (SBL) (41.7 
nM). In the second phase, verapamil (VER) (2.03 μM), SBL (41.7 nM), and SJ (0.41 and 4.01 mg/ml) 
were applied to the tissues after pre-contraction with K+ (80 mM). In the third phase, the effects of VER, 
SBL, and SJ on CaCl2-induced contractions (0.03 – 10.83 mM) were examined. In the fourth and final 
phases, the second phase experiments were repeated in a calcium-free medium and in the absence 
and presence of propranolol (1.54 mM) respectively.  
Results: SJ exhibited significant inhibitory effects on OT and CaCl2 induced uterine contractions (p < 
0.05). The EC50 for OT increased from 1.92 ± 0.12 to 7.16 ± 0.16 nM and that for CaCl2 increased from 
0.19 ± 0.09 to 0.76 ± 0.11 mM in the presence of the extract. SJ also significantly inhibited KCl- induced 
contraction by 39.15 ± 2.13 and 53.23 ± 1.58 %  for 0.41 and 4.01 mg/ml of the extract, respectively (p < 
0.01); this inhibition was unaffected by propranolol. On the other hand, SBL and VER showed inhibition 
of 77.25 ± 1.85 and 79.44 ± 2.27 %, respectively.  
Conclusion: SJ exerts uterine inhibitory effects in rats which appear unrelated to β2-adrenergic 
receptor stimulation but possibly through inhibition of calcium entry into the cytoplasm. 
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Starchytarpeta jamaicensis (L.) Vahl 
(Verbanaceae) popularly called Gervao, 
Brazillian tea and Bastard vervain is used 
extensively by indigenous people throughout the 
Amazons and tropical countries for the treatment 
of various ailments with a wide range of uses in 
ethnomedicinal practice. The plant has been 
reported to have reasonable antimicrobial and 
insecticidal properties [4]. Previous laboratory 
studies have verified its longstanding use in the 
treatment of gastrointestinal tract, and 
cardiovascular disorders. The aqueous extract of 
the leaves has been shown to cause a dose 
dependent decrease in the mean systolic, 
diastolic; mean arterial pressure and heart rate in 
normotensive male albino rabbits [5]. S. 
jamaicensis is also claimed to have abortifacient 
properties. Anecdotal evidence indicate that and 
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some Nigerian communities use some parts of 
the plant to induce abortion. Despite the claim of 
its abortifacient activity in traditional medicine 
practice, no record of scientific validation has 
been reported to our knowledge. This work was 
thus set out to investigate the effect of the 
methanol leaf extract of S. jamaicensis (SJ) on 
the uterine smooth muscles of non-pregnant 
adult female Sprague-Dawley rats, and possibly 




Drugs and chemicals 
 
Diethylstilboesterol, salbutamol and propranolol 
were obtained from Sigma (UK), oxytocin 
(Laborate Pharmaceuticals, India), verapamil 
(May and Baker, UK). These were all prepared 
fresh on the day of the experiment. 
 
Plant preparation and extraction 
 
The leaves of SJ were collected from the 
premises of the University of Benin, Benin City, 
Nigeria, identified and authenticated by Professor 
Macdonald Idu of the Department of Plant 
Biology and Biotechnology of the University of 
Benin, Nigeria. The plant was provided with a 
herbarium number of UBHv0259a and a 
herbarium specimen was prepared and stored in 
the Herbarium Section of the Department of 
Plant Biology and Biotechnology, University of 
Benin. The leaves of the plant were washed free 
of earthy materials, air dried for seven days and 
further dried in an oven at 40 ºC for 2 h. A portion 
of the powdered plant material (500 g) was 
extracted with methanol, using cold maceration 
for 72 h and the extract was then concentrated to 
dryness in an oven maintained at 40 ºC. The 




Adult female Sprague-Dawley rats (170-200 g) 
bred in the animal unit of the Department of 
Pharmacology and Toxicology, University of 
Benin were used. Animal care and experimental 
procedures complied with standard guidelines for 
use of laboratory animals (National Institute of 
Health USA: Public Health Service Policy on 
Humane Care and Use of Laboratory animals, 
2002) [6]. This involved maintenance of animals 
under standard conditions with free access to 
standard diet (Bendel Feeds and Flour Mill, Ewu, 
Nigeria) and water. Ethical clearance was 
obtained from the Ethical Committee for Animal 
Studies, Faculty of Pharmacy, University of 
Benin, Benin City prior to commencement of the 
study.  
Preparation of animals for uterine studies  
 
Uterine segments of the rats were obtained and 
prepared for the in vitro studies as previously 
described [7]. Briefly, the animals were treated 
with diethylstilboesterol (0.2 mg/kg i.p.) 24 h prior 
to the commencement of the experiment. The 
oestrus stage was confirmed by microscopic 
observation of vaginal smears and macroscopic 
observation of the vulva. Rats were sacrificed 
under diethylether anaesthesia and the uterine 
horns rapidly dissected out and placed in 
previously warmed and aerated physiological salt 
solution (PSS) composed of  Cl (154 mM), KCl 
(5.63 mM), CaCl2.2H20 (0.648 mM), NaHCO3 
(5.95 mM) and D-glucose (2.77 mM). Uterine 
segments, 2 cm in length, were cut and freed of 
adhering connective tissues and fat. The 
segments were mounted longitudinally in 40 ml 
organ baths containing PSS of the following. The 
lower ends of the tissue were attached to tissue 
holders by means of silk suture and the upper 
ends to an isometric force-displacement 
transducer (Model 82145, Ugo Basile, Monvalle 
VA, Italy) connected to a unirecorder (Model 
7050, Ugo Basile, Monvalle VA, Italy). The PSS 
was maintained at 37 oC and continuously 
aerated.  Each uterine segment was placed 
under optimum resting tension of 0.75 g and 
equilibrated for 45 min before the start of the 
experiment. During the equilibration period, the 
preparations were washed with the PSS every 10 
min [8].  
 
Study on the inhibition of concentration – 
response curves to oxytocin 
 
Concentration – response curves for oxytocin 
(OT) (0.79 – 159.88 M) were obtained for the 
uterine tissues in the absence and presence of 
salbutamol (SBL) (41.7 nM) or SJ (0.41 and 4.01 
mg/ml). 
 
Study on the inhibition of K+-induced 
contraction  
 
To determine the possibility of calcium channel 
blockade by SJ, the uterine preparations were 
depolarized with K+ using a modified method (9). 
Addition of K+ (80 mM) produced a sustained 
contraction to which verapamil (VER) (2.03 μM), 
SBL (41.7 nM) or SJ (0.41 and 4.01 mg/ml) were 
added cumulatively.  
 
Study on the inhibition of CaCl2-induced 
contractions 
 
The effect of SJ on CaCl2-induced uterine 
contractions was examined as previously 
described [10]. The uterine tissue was 
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equilibrated in normal PSS for 30 min, which was 
then replaced with Ca2+-free PSS containing 
ethylenediamine tetra-acetic acid (EDTA, 0.1 
mM) for 30 min. This solution was further 
replaced with K+-rich and Ca2+-free PSS, 
composed of KCl (50 mM), NaCl (154 mM), 
NaHCO3 (5.95 mM), D-Glucose (2.77 mM), 
CaCl2.2H2O (0.648 mM) and EDTA (0.1 mM). 
The tissues were re-equilibrated for a period of 
30 min. Concentration – response curves (CRCs) 
for Ca2+ (0.03 – 10.83 mM) alone were 
constructed and regarded as control. The tissues 
were subsequently incubated with SJ (0.41 and 
4.01 mg/ml) for 15 min and without washing, the 
CRC to Ca2+ was repeated. This was necessary 
in order to examine the possible calcium channel 
blocking effect of the extract.  The CRCs of Ca2+ 
were also repeated in the presence of VER (2.03 
μM) and SBL (41.7 nM) in separate experiments. 
 
Study on the inhibition of OT-induced 
contraction in Ca2+- free PSS 
 
A modified method [11] was employed for this 
phase of the study. Briefly, the uterine tissues 
were equilibrated for 60 min under a resting 
tension of 0.7 g and washed every 15 min. 
Subsequently, the medium was changed to Ca2+-
free PSS containing 0.1 mM EDTA and the 
tissues were further equilibrated for 50 min with 
intermittent washings every 10 min. Cumulative 
CRC to OT (0.04 – 3.19 mM) was repeated in the 
presence of SJ, VER, and SBL in concentrations 
previously mentioned.  
 
Study on the effect of propranolol on 
inhibition of oxytocin – induced contraction 
 
Propranolol (1.54 mM) was added to the organ 
bath for 15 min, thereafter CRCs to oxytocin was 
determined in the presence of SJ, SBL or VER in 
concentrations previously mentioned. 
 
Curve fitting and statistical analyses of 
contraction assays 
 
Values were presented as mean ± standard error 
of mean (SEM) and n represented the number of 
animals for each set of experiments. The 
responses were expressed as a percentage of 
control amplitude (g) of uterine contractions. In 
datasets with sufficient data points,  mean log 
concentration –response curves were analyzed 
by fitting data to a four-parameter logistic 
equation, using non-linear regression with 
GraphPad Prism 4.0 (GraphPad Software, San 
Diego, CA, USA) to determine the pEC50 values 
(Y = Bottom + (Top-Bottom)/(1+10^((LogEC50-
X)*HillSlope)). Where Y = response which starts 
at the Bottom and goes to the Top in sigmoid 
shape, X = logarithm of concentration and EC50 
is the concentration that produces half the 
maximal responses. Average potencies for 
frequency and amplitude of contractions were 
calculated and compared after curve fitting where 
possible. Statistical analysis was performed 
using one-way ANOVA with Dunnett’s multiple 
comparison tests. P ≤ 0.05 indicated statistical 




Inhibition of concentration–response curves 
to oxytocin 
 
SJ significantly (p < 0.05) inhibited OT-induced 
uterine contractions. This was observed in the 
rightward shift of the CRC to OT, significant 
increase (p < 0.05) of the EC50 (Table 1) and 
reduction of the Emax (Fig. 1) of OT in a 
concentration-dependent manner. Similarly, SBL 
and VER significantly increased (p < 0.01) the 
EC50 (Table 1) and reduced the Emax (Figure 1A) 
of OT respectively. 
 
Inhibition of CaCl2- induced contractions 
 
SJ shifted the CRC of CaCl2-induced uterine 
contractions to the right (Figure 1B) and 
significantly increased (p < 0.05) the EC50 (Table 
1) and reduced the Emax (Figure 1B).VER, and 
SBL also significantly inhibited CaCl2 (p < 0.01) 
(Figure 1B and Table 2). 
 
Inhibition of K+ - induced contraction  
 
SJ significantly inhibited (p < 0.01) the sustained 
uterine contraction produced by, K+ (80 mM) in a 
concentration-dependent manner (Table 2). 
VER, and SBL also produced similar but more 
potent inhibition of K+ (p < 0.01) (Table 2). 
 
Inhibition of OT-induced contraction in Ca2+- 
free PSS 
 
SJ and VER did not significantly inhibit OT-
induced contractions in Ca2+ free medium (Figure 
3). It was also observed that there was no 
significant difference in the EC50 (Table 3). 
However, SBL was observed to produce 
significant reduction (p < 0.01) in the EC50 of OT 
(Table 3) and a rightward shift in the CRC of OT 
(Figure 2). 
 
Effect of propranolol on inhibition of 
oxytocin–induced contraction 
 
After addition of propranolol (1.54 mM) for 15 
min, it was observed that propranolol failed to 
attenuate the effect of SJ and VER on OT-
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induced contractions; however the effect of SBL 





Figure 1: Concentration–response curves (CRC) for 
OT in the presence and absence of SJ and SBL (A) 
and CRC for CaCl2 in the presence and absence of 
SJ, VER and SBL (B). n= 6 rats. SJ shifted the CRC of 
OT and CaCl2-induced uterine contractions to the right 
and significantly reduced (p<0.05) the EC50 (Table. 1) 
and Emax. VER and SBL also significantly inhibited 
CaCl2 and OT (p<0.01). For Figure 1A: ■ OT alone; 
▲OT + SJ (0.41 mg/ml); ▼OT + SJ (4.01 mg/ml); ♦ 
OT + SBL (41.7 nM). For Figure 1B: ■ CaCl2 alone; ∆ 
CaCl2 + SJ (0.41 mg/ml); ▼ CaCl2 + SJ (4.01 mg/ml); 
◊ CaCl2 + VER (2.03 µM);  CaCl2 + SBL (41.7 nM) 
 
Table 1: EC50 values obtained from the concentration–




OT alone (Control) 1.92 ± 0.12 (nM) 
OT + SJ (0.41 mg/ml) 6.59 ± 0.23 (nM) * 
OT + SJ (4.01 mg/ml) 7.16 ± 0.16 (nM)* 
OT + SBL (41.71 nM) 24.54 ± 0.16 (nM)** 
CaCl2  
CaCl2 alone (Control) 0.19 ± 0.09 (mM) 
CaCl2 +SJ (0.41 mg/ml) 0.47 ± 0.11 (mM)^ 
CaCl2 + SJ (4.01 mg/ml) 0.51 ± 0.25 (mM)^ 
CaCl2 + SBL  (41.71 nM) 0.76 ± 0.11 (mM)^^ 
CaCl2 + VER (2.03 μM) 0.92 ± 0.18 (mM)^^ 
*P < 0.05; **p < 0.01 all compared to OT alone; ^p < 
0.05; ^^p < 0.01 all compared to CaCl2 alone; n = 6 
rats 
Table 2: Effect of S. jamaicensis (SJ), verapamil 
(VER) and salbutamol (SBL) on K+ - induced sustained 
contraction 
 
Concentration Inhibition of KCl 
(%) 
SJ (0.41 mg/ml) 39.15 ± 2.12** 
SJ (4.01 mg/ml) 53. 23  ± 1.58** 
SBL (41.71 nM) 77.25  ± 1.85** 
VER (2.03 μM) 79.44  ± 2.27** 




Figure 2: Concentration – response curves for OT in 
Ca2+ free medium (A) and in the presence of 
propranolol (B). SJ and VER did not significantly inhibit 
OT-induced contractions (A). However, SBL produced 
a rightward shift in the CRC of OT (B). In the presence 
of propranolol (1.54 mM), the effect of SJ on OT was 
not attenuated however the effect of SBL on OT was 
significantly (p < 0.05) overcome (B); n = 6 rats.  ■ OT 
alone; ▲OT + SJ (0.41 mg/ml); ▼OT + SJ (4.01 




The methanol leaf extract of S. jamaicensis (SJ) 
has been shown in this study to inhibit oxytocin-
induced uterine contractions. On comparison, a 
similar effect was observed with salbutamol and 
verapamil both of which possesses inhibitory 
actions on uterine contraction. 
 
Salbutamol is a ß-adrenoceptor agonist that acts 
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(in Ca2+ free medium) 
EC50 
(in presence of propranolol) 
OT alone 0.51 (mM) 1.96 ± 0.17 (nM) 
OT + SJ (0.41 mg/ml) 0.66 (mM) 6.63 ± 0.14 (nM) ** 
OT + SJ (4.01 mg/ml) 0.69 (mM) 7.18 ± 0.31 (nM) ** 
OT + SBL (41.71 nM) 1.47 (mM)* 2.02 ± 1.63 (nM) 
OT + VER (2.03 μM) 0.58 (mM) 15.87 ± 0.76 (nM)** 
      ** p < 0.01 compared to OT alone; n = 6 rats; **p < 0.01 
 
physiologically to antagonize contractions of the 
uterus this effect makes it a clinically useful 
tocolytic agent [11], while verapamil, a 
phenylalkylamine calcium channel blocker also 
antagonizes contractions of the uterus by 
inhibition of voltage-dependent calcium channels 
[12]. Oxytocin contracts the uterine smooth 
muscle by stimulating specific receptors, which 
amongst other actions activates second 
messenger systems to release intracellular 
stored calcium from the sarcoplasmic reticulum 
[13].  
 
Thus SJ may have inhibited the calcium influx 
into the cell cytoplasm or interfered with one of 
the biochemical processes associated with the 
influx of calcium into the myometrial smooth 
muscle cells. This observation was further 
supported by the concentration-dependent 
relaxant effect of SJ on high K+-induced 
contractions. Relaxation of K+-induced sustained 
contractions by SJ just like the Ca2+ channel 
blocker, verapamil suggests possible calcium 
channel blockade by SJ [14]. Contraction of the 
isolated uterine smooth muscles by high K+ in 
extracellular fluid is known to depolarize smooth 
muscle membranes, and to open the voltage - 
operated calcium channels (VOCs), in particular, 
the L-type calcium channel [13,14]. The resultant 
effect is the influx of calcium into the smooth 
muscle cells which culminates in contraction. The 
contraction is usually a biphasic response that 
consists of an initial, rapid, transitory contraction, 
the phasic response, followed by a slower more 
sustained contraction, the tonic response (14). 
This mechanical response to high K+ is 
completely inhibited by several calcium channel 
blockers through blockade of L-type channel. 
Inhibition of both OT and CaCl2-induced 
contractions may indicate that the spasmolytic 
principle contained in the extract is not a specific 
receptor antagonist.  
 
Possible intracellular activity of SJ was examined 
by observing the influence of SJ on contractions 
induced by OT in Ca2+ free PSS. The 
contractions obtained in these conditions, are 
described as related only to release of calcium 
from intracellular stores [14]. Interestingly, SJ 
and VER were found in this study to show 
insignificant inhibition and it has been reported 
that nifedipine (also a Ca2+ channel antagonist) 
failed to inhibit the sustained contractions 
induced by OT in Ca2+ free PSS [15]. SBL 
however was observed to inhibit OT under this 
condition. This observation is supported by 
reports that ß2-stimulants inhibit OT-induced 
contractions in Ca2+ free medium [16]. 
 
The possibility of ß- adrenoceptor activation by 
the extract of SJ was also investigated and it was 
observed that SJ as well as VER inhibited OT in 
the presence of propranolol. However, SBL failed 
to produce similar response in the presence of 
propranolol, apparently due to blockade of ß- 
adrenoceptors. This result suggests that the 





The findings of this study reveal that at 
concentrations used in this study, SJ inhibits OT-
induced uterine contractions in 
diethylstilboesterol-pretreated rats. This inhibitory 
effect is unrelated to β-adrenoceptor stimulation 
but might be through the inhibition of extracellular 
calcium influx or by some other mechanism 
which affects calcium influx and utilization in the 
uterine smooth muscle. Further studies however, 
are needed to determine the precise mechanism 
of uterine relaxation and to examine other 
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